Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pain

U.S. Sen. Markey Places Hold on Obama’s Nominee to Lead FDA

Toni Clarke  |  January 26, 2016

(Reuters)—U.S. Sen. Edward Markey (D-Mass.) said on Monday he has placed a hold on President Barack Obama’s nominee to head the U.S. Food and Drug Administration until the agency agrees to reform its process for approving opioid painkillers. Markey wants future opioid-approval matters to be reviewed by an FDA advisory committee, and believes the committee…

Filed under:AnalgesicsDrug UpdatesLegislation & AdvocacyProfessional Topics Tagged with:AddictionApprovalsChildrenDrug SafetyFDAFood and Drug AdministrationhydrocodoneOpioidsPain

Ethics Forum: Physicians Face Ethical Quandary Discussing Poor Prognosis with Patients

Rashmi Shah, MD, Jennifer Barton, MD, & Robert H. Shmerling, MD  |  January 19, 2016

Over the course of a month, you diagnose systemic sclerosis in two newly evaluated patients. Their responses to the news could not be more different. Patient 1 is a previously healthy 55-year-old man who is an avid bicyclist and skier. He presents with a several-month history of rapidly progressive skin tightening extending to the proximal…

Filed under:EthicsPractice SupportProfessional Topics Tagged with:Ethicspatient communicationphysicianprognosis

ICD-10: An Ode to Code

Robert H. Shmerling, MD  |  January 19, 2016

When the code that you need is not clear Just keep this poem quite near If you’re struck by a parrot Just grin and bear it ICD-10 has you covered my dear. W61.02XA Struck by parrot, initial encounter And if you’re ever struck by a cow I don’t even want to know how Rest assured:…

Filed under:Billing/CodingPractice Support Tagged with:BillingCodingICD-10physician

The ACR/ARHP Award Winners Discuss Their Contributions to Rheumatology

Richard Quinn  |  January 19, 2016

At the 2015 ACR/ARHP Annual Meeting in San Francisco in November, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. In the December 2015 issue, The Rheumatologist reported on the ACR’s awards. This month, we speak with the ARHP winners about…

Filed under:AwardsCareer DevelopmentProfessional Topics Tagged with:ACR/ARHPAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)Awardswinner

Pharmaceutical Care Models, Tools for Treating Patients with Rheumatoid Arthritis

Louise Grech, BPharm (Hons), MPhil, MRPharmS, Victor Ferrito, BSc, MSc, PhD, CSci, Liberato Camilleri, BEd, MSc, PhD, Anthony Serracino Inglott, BPharm, PharmD, MRPharmS, & Lilian M. Azzopardi, BPharm (Hons), MPhil, PhD, MRPharmS  |  January 19, 2016

Rheumatoid arthritis (RA) can be defined as a chronic autoimmune systemic inflammatory condition characterized by symmetrical polyarthritis. Typically, patients present with pain, stiffness and warmth of the affected joints. The condition can result in extra-articular features, adding to disability, and may eventually lead to premature death, especially if not treated early and appropriately.1,2 Over the…

Filed under:ConditionsRheumatoid Arthritis Tagged with:Drugspatient carepharmaceuticalRheumatoid arthritistherapyTreatment

How to Choose the xBest Course of Treatment to Manage Rheumatoid Arthritis

How to Choose the Best Course of Treatment to Manage Rheumatoid Arthritis

Karen Appold  |  January 19, 2016

Diagnosing rheumatoid arthritis (RA) early in the disease process is ideal, because treatments are more likely to be effective and less damage will occur. Guidelines from the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) state that using newer biologic medications, in addition to more aggressive dosing of traditional medications, is…

Filed under:ConditionsRheumatoid Arthritis Tagged with:Managementpatient careRheumatoid arthritistherapyTreatment

American Physical Therapists Collaborate with Local PTs in Ethiopia

Mary E. Christenson, PT, PhD  |  January 19, 2016

Ethiopia has a rich, variable and distinguished history and landscape. Located in the Horn of Africa, it shares borders with Eritrea, Djibouti, Somalia, Kenya, Sudan and South Sudan. Ethiopia has claim to the oldest humanoid fossils, named “Lucy,” which were discovered in 1974 and are estimated to be 3.2 million years of age.1 The country’s…

Filed under:Profiles Tagged with:Ethiopiaglobalpatient carePhysical Therapy

French ‘Cannabis’ Drug Trial Leaves 1 Brain Dead, 5 Injured

Matthias Blamont  |  January 19, 2016

PARIS (Reuters)—One person has been left brain dead and five others are in a serious condition after taking part in a clinical trial in western France of an experimental medicine from an unnamed drug company, the French health ministry said on Friday, Jan. 15. The ministry did not say what the medicine was intended to be used…

Filed under:AnalgesicsDrug Updates Tagged with:cannabisclinical trialsDrugsFranceInternationalPain

Drug Shortages in U.S. Emergency Departments on the Rise

Madeline Kennedy  |  January 17, 2016

(Reuters Health)—U.S. emergency rooms are increasingly running short on medications, including many that are needed for life-threatening conditions, a recent study documents. Since 2008, the number of shortages has risen by more than 400%, researchers found. Half of all emergency room shortages were for life-saving drugs, and for one in 10 there were no available…

Filed under:Drug Updates Tagged with:Drug shortageemergencyEmergency Departmenthospital

Major Drugmakers Push Back in U.S. Price Debate

Caroline Humer  |  January 15, 2016

SAN FRANCISCO (Reuters)—With a backlash brewing over the price of medicines in the U.S., drugmakers are pushing back with a new message: Most people don’t pay retail. Top executives from Eli Lilly and Co, Merck & Co and Biogen Inc. said in interviews with Reuters this week that the media focus on retail, or “list…

Filed under:Drug Updates Tagged with:costsDrugsOut-of-pocket costsPatient costsPfizer Inc.pharmaceutical company

  • « Previous Page
  • 1
  • …
  • 163
  • 164
  • 165
  • 166
  • 167
  • …
  • 245
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences